Cargando…

PB2302: HEPARIN-INDUCED THROMBOCYTOPENIA ANTIBODIES CAN MAINTAIN PLATELET-ACTIVATING PROPERTIES AFTER TWO SESSIONS OF THERAPEUTIC PLASMA EXCHANGE

Detalles Bibliográficos
Autores principales: Gkalea, V., Tseke, P., Pappas, T., Kotsiauti, A., Petrou, V., Psimenou, E., Matsouka, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431709/
http://dx.doi.org/10.1097/01.HS9.0000852036.48749.5c
_version_ 1784780130032287744
author Gkalea, V.
Tseke, P.
Pappas, T.
Kotsiauti, A.
Petrou, V.
Psimenou, E.
Matsouka, C.
author_facet Gkalea, V.
Tseke, P.
Pappas, T.
Kotsiauti, A.
Petrou, V.
Psimenou, E.
Matsouka, C.
author_sort Gkalea, V.
collection PubMed
description
format Online
Article
Text
id pubmed-9431709
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94317092022-08-31 PB2302: HEPARIN-INDUCED THROMBOCYTOPENIA ANTIBODIES CAN MAINTAIN PLATELET-ACTIVATING PROPERTIES AFTER TWO SESSIONS OF THERAPEUTIC PLASMA EXCHANGE Gkalea, V. Tseke, P. Pappas, T. Kotsiauti, A. Petrou, V. Psimenou, E. Matsouka, C. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431709/ http://dx.doi.org/10.1097/01.HS9.0000852036.48749.5c Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Gkalea, V.
Tseke, P.
Pappas, T.
Kotsiauti, A.
Petrou, V.
Psimenou, E.
Matsouka, C.
PB2302: HEPARIN-INDUCED THROMBOCYTOPENIA ANTIBODIES CAN MAINTAIN PLATELET-ACTIVATING PROPERTIES AFTER TWO SESSIONS OF THERAPEUTIC PLASMA EXCHANGE
title PB2302: HEPARIN-INDUCED THROMBOCYTOPENIA ANTIBODIES CAN MAINTAIN PLATELET-ACTIVATING PROPERTIES AFTER TWO SESSIONS OF THERAPEUTIC PLASMA EXCHANGE
title_full PB2302: HEPARIN-INDUCED THROMBOCYTOPENIA ANTIBODIES CAN MAINTAIN PLATELET-ACTIVATING PROPERTIES AFTER TWO SESSIONS OF THERAPEUTIC PLASMA EXCHANGE
title_fullStr PB2302: HEPARIN-INDUCED THROMBOCYTOPENIA ANTIBODIES CAN MAINTAIN PLATELET-ACTIVATING PROPERTIES AFTER TWO SESSIONS OF THERAPEUTIC PLASMA EXCHANGE
title_full_unstemmed PB2302: HEPARIN-INDUCED THROMBOCYTOPENIA ANTIBODIES CAN MAINTAIN PLATELET-ACTIVATING PROPERTIES AFTER TWO SESSIONS OF THERAPEUTIC PLASMA EXCHANGE
title_short PB2302: HEPARIN-INDUCED THROMBOCYTOPENIA ANTIBODIES CAN MAINTAIN PLATELET-ACTIVATING PROPERTIES AFTER TWO SESSIONS OF THERAPEUTIC PLASMA EXCHANGE
title_sort pb2302: heparin-induced thrombocytopenia antibodies can maintain platelet-activating properties after two sessions of therapeutic plasma exchange
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431709/
http://dx.doi.org/10.1097/01.HS9.0000852036.48749.5c
work_keys_str_mv AT gkaleav pb2302heparininducedthrombocytopeniaantibodiescanmaintainplateletactivatingpropertiesaftertwosessionsoftherapeuticplasmaexchange
AT tsekep pb2302heparininducedthrombocytopeniaantibodiescanmaintainplateletactivatingpropertiesaftertwosessionsoftherapeuticplasmaexchange
AT pappast pb2302heparininducedthrombocytopeniaantibodiescanmaintainplateletactivatingpropertiesaftertwosessionsoftherapeuticplasmaexchange
AT kotsiautia pb2302heparininducedthrombocytopeniaantibodiescanmaintainplateletactivatingpropertiesaftertwosessionsoftherapeuticplasmaexchange
AT petrouv pb2302heparininducedthrombocytopeniaantibodiescanmaintainplateletactivatingpropertiesaftertwosessionsoftherapeuticplasmaexchange
AT psimenoue pb2302heparininducedthrombocytopeniaantibodiescanmaintainplateletactivatingpropertiesaftertwosessionsoftherapeuticplasmaexchange
AT matsoukac pb2302heparininducedthrombocytopeniaantibodiescanmaintainplateletactivatingpropertiesaftertwosessionsoftherapeuticplasmaexchange